| Name | N-phenyl-4-(quinolin-3-ylmethyl)piperidine-1-carboxamide |
|---|---|
| Synonyms |
N-Phenyl-4-(3-quinolinylmethyl)-1-piperidinecarboxamide
1-Piperidinecarboxamide, N-phenyl-4-(3-quinolinylmethyl)- N-Phenyl-4-(quinolin-3-ylmethyl)piperidine-1-carboxamide PF-750 Nisoxetine hydrochloride |
| Description | PF 750 is a selective and covalent fatty acid amide hydrolase (FAAH) inhibitor, with IC50s varied from 16.2-595 nM in different pre-incubation times. Covalently modifies the enzyme’s active site serine nucleophile[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 16.2-595 nM (FAAH)[1]. |
| References |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 582.7±32.0 °C at 760 mmHg |
| Molecular Formula | C22H23N3O |
| Molecular Weight | 345.438 |
| Flash Point | 306.2±25.1 °C |
| Exact Mass | 345.184113 |
| PSA | 45.23000 |
| LogP | 3.77 |
| Vapour Pressure | 0.0±1.6 mmHg at 25°C |
| Index of Refraction | 1.672 |